Portuguese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
International Journal of Obesity 1984

Long-term effects of small intestinal bypass on hepatic lipid content in congenitally obese rats.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
O link é salvo na área de transferência
D L Kaminski
E Mueller
M Jellinek

Palavras-chave

Resumo

This study compares the early (30-d) with the late (14-month) effects of small intestinal bypass on hepatic lipid accumulation in congenitally obese Zucker rats. Heterozygote, lean and homozygote, obese Zucker rats underwent sham operations and homozygote obese rats underwent bypass of 90 percent of their small intestine. Evaluation of hepatic lipid content at 30 d following the operation demonstrated increased hepatic triglyceride content in homozygote obese rats compared to heterozygote lean rats; however, the homozygote rats with small intestinal bypass did not have significantly different hepatic triglyceride content from that present in the homozygote obese sham operated rats. Fourteen months following the operations hepatic lipid content increased from 63 +/- 14 mg/g liver in homozygote, obese sham operated rats to 132 +/- 55 mg/g in homozygote, obese rats with small intestinal bypass. The increased lipid was secondary to increased hepatic triglyceride content. Histologic evaluations of liver specimens demonstrated no increased inflammation, granuloma formation or fibrosis when sham operated rat liver tissue was compared to liver tissue from rats with intestinal bypass. These data indicate that at a late stage following small intestinal bypass, the obese Zucker rat develops hepatic steatosis, as do humans, and can serve as an experimental model for evaluation of methods to decrease the triglyceride accumulation.

Junte-se à nossa
página do facebook

O mais completo banco de dados de ervas medicinais apoiado pela ciência

  • Funciona em 55 idiomas
  • Curas herbais apoiadas pela ciência
  • Reconhecimento de ervas por imagem
  • Mapa GPS interativo - marcar ervas no local (em breve)
  • Leia publicações científicas relacionadas à sua pesquisa
  • Pesquise ervas medicinais por seus efeitos
  • Organize seus interesses e mantenha-se atualizado com as notícias de pesquisa, testes clínicos e patentes

Digite um sintoma ou doença e leia sobre ervas que podem ajudar, digite uma erva e veja as doenças e sintomas contra os quais ela é usada.
* Todas as informações são baseadas em pesquisas científicas publicadas

Google Play badgeApp Store badge